Adenocarcinoma of the Esophagogastrgic Junction

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-02-24
Clinical Trial Update: Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating the TGF-beta receptor I inhibitor Vactosertib in combination with standard-of-care chemoradiotherapy for locally ad…